Crossmark

How can we consider variable RBE and LETd prediction during clinical practice? A pediatric case report at the Normandy Proton Therapy Centre using an independent dose engine

Crossref DOI link: https://doi.org/10.1186/s13014-021-01960-w

Published Online: 2022-02-04

Published Print: 2022-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Mein, Stewart

Kopp, Benedikt

Vela, Anthony

Dutheil, Pauline

Lesueur, Paul

Stefan, Dinu

Debus, Jürgen

Haberer, Thomas

Abdollahi, Amir

Mairani, Andrea

Tessonnier, Thomas https://orcid.org/0000-0002-8919-4299
Funding

Funding for this research was provided by:

Universitätsklinikum Heidelberg
License Information

Text and Data Mining valid from 2022-02-04

Version of Record valid from 2022-02-04
More Information

Article History

Received: 22 June 2021

Accepted: 1 December 2021

First Online: 4 February 2022

Declarations

:

: Internal ethics approval and consent was acquired for this study. Patient records were anonymized prior to the study, obtained with informed consent and handled following the Helsinki Declaration.

: All patients at the NPTC provided consent for data usage in study and publication.

: Not Applicable.

Document is current

Any future updates will be listed below